SLC5A2 and diabetes mellitus: In addition to insulin and mitochondrial-targeted therapies, metabolic modulators like sodium-glucose cotransporter 2 (SGLT2) inhibitors, commonly used to treat diabetes, are being investigated for their potential to enhance wound healing [152].